Compare IVVD & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVVD | IIIV |
|---|---|---|
| Founded | 2020 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 659.8M | 753.1M |
| IPO Year | 2021 | 2018 |
| Metric | IVVD | IIIV |
|---|---|---|
| Price | $2.11 | $24.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $8.75 | ★ $33.33 |
| AVG Volume (30 Days) | ★ 3.2M | 256.1K |
| Earning Date | 11-06-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.56 |
| Revenue | $50,039,000.00 | ★ $213,158,000.00 |
| Revenue This Year | $107.86 | $8.32 |
| Revenue Next Year | $146.53 | $7.26 |
| P/E Ratio | ★ N/A | $173.57 |
| Revenue Growth | ★ 332.71 | 11.47 |
| 52 Week Low | $0.35 | $22.00 |
| 52 Week High | $3.07 | $33.97 |
| Indicator | IVVD | IIIV |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 37.37 |
| Support Level | $2.15 | $24.00 |
| Resistance Level | $2.31 | $25.39 |
| Average True Range (ATR) | 0.19 | 1.04 |
| MACD | -0.05 | -0.27 |
| Stochastic Oscillator | 2.90 | 6.99 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.